ワクチンの世界市場：技術 (生、トキソイド、遺伝子組み換え)・疾患 (肺炎球菌、インフルエンザ、DTP、HPV、肝炎、髄膜炎菌性疾患、ロタウイルス、小児まひ、MMR、水痘、デング熱)・投与経路 (筋肉内／皮下投与、経口投与)・患者 (小児、成人)・種類別の予測 (2023年まで)
Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023
|出版日||ページ情報||英文 185 Pages
|ワクチンの世界市場：技術 (生、トキソイド、遺伝子組み換え)・疾患 (肺炎球菌、インフルエンザ、DTP、HPV、肝炎、髄膜炎菌性疾患、ロタウイルス、小児まひ、MMR、水痘、デング熱)・投与経路 (筋肉内／皮下投与、経口投与)・患者 (小児、成人)・種類別の予測 (2023年まで) Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023|
|出版日: 2018年08月14日||ページ情報: 英文 185 Pages||
世界のワクチン市場は、2018年には364億5000万米ドル、2023年には504億2000万米ドルと、6.7%のCAGR (複合年間成長率) で拡大する見通しです。市場の主要な成長要因として、各種疾患の患者数の多さや、政府や民間団体からのワクチン開発への援助、企業の研究開発 (R&D) 強化などが挙げられます。
The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing company initiatives to enhance R&D are driving the growth of the vaccines market. On the other hand, market growth may be hindered due to the high cost of vaccine development.
Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent segment is expected to dominate this market with the largest share due to increasing investments by companies to develop new vaccines.
Based on the disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, herpes zoster, dengue, and other disease indications. The pneumococcal segment is expected to account for the largest share of the vaccines market in 2018. The large share of this segment can primarily be attributed to increasing government investments in pneumococcal vaccination programs and high incidence of pneumococcal diseases.
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.
The primary interviews conducted for this report can be categorized as follows:
List of companies profiled in the report:
The report provides an overview of the vaccines market. It aims at estimating the market size and future growth potential of this market across different segments such as technology, type, disease indication, route of administration, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall vaccines market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.